This role offers the opportunity to lead late-stage cell therapy programs that can redefine outcomes for patients with prostate cancer. The position involves transforming cutting-edge science into decisive clinical evidence to inform regulators, payers, and clinicians globally. The lead will manage a significant portion of a complex, indication-aligned cluster of studies within a prostate cancer cell therapy program. Responsibilities include partnering with study physicians and clinical scientists to shape study design, oversee conduct and monitoring, and drive data interpretation to determine the benefit-risk profile, intended label, and global value proposition. The role requires translating novel biology into pivotal trials that withstand regulatory scrutiny and deliver real-world impact. Working across diverse expert teams and external partners, the lead will co-lead product and study strategy, set a clear vision, and enable timely decisions, leveraging innovative tools like biomarkers and advanced trial designs to keep the program competitive and bring transformative therapies to patients sooner.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior